Lam Ka-Hoo, van Munster Caspar E P, D'Souza Marcus, Steinheimer Saskia, Kamm Christian P, Burggraaff Jessica, Johnson Matthew, Zaykov Yordan, Dorn Jonas, Dahlke Frank, Kappos Ludwig, Killestein Joep, Uitdehaag Bernard
Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands (CEPvM, K-HL, JB, JK, BU).
Neurologic Clinic and Polyclinic, Departments of Medicine, Biomedicine, and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland (MD, LK).
Int J MS Care. 2022 Sep-Oct;24(5):230-234. doi: 10.7224/1537-2073.2021-044. Epub 2022 Jun 20.
Assessing motor functioning is important to monitor the disease course of multiple sclerosis (MS). Video-assisted rating of classic neurologic tests and activities of daily living may improve the detection of changes in motor functioning. We investigated the value of using video-assisted composite measures for the detection of changes in mobility and upper extremity function (UEF).
Forty-three patients with MS were recorded performing motor function tests before and during treatment with fampridine. Patients were classified as improved or not improved on mobility composite (MOB-COM) and UEF composite (UEF-COM) measures based on neurologists' ratings of the tests. The proportional agreements between the composite measures and the conventional measures-the Timed 25-Foot Walk test (T25FW) and the Nine-Hole Peg Test (NHPT)-were determined and compared with patient-perceived improvement, which was determined using patient-reported ratings of changes in mobility and UEF.
Agreement between MOB-COM and T25FW was 79.5%, and agreement between UEF-COM and NHPT was 82.1%. Twenty-six of 39 patients (66.7%) reported mobility improvement; 6 of these reports were confirmed by both T25FW and MOB-COM, 4 were confirmed by T25FW only, and 2 were confirmed by MOB-COM only. For UEF, 13 of 39 patients (33.3%) reported improvement; 3 of these were confirmed by the NHPT and 3 were confirmed by the UEF-COM.
Compared with the conventional NHPT measure, the video-assisted composite measure of UEF detected additional patient-perceived improvement. This was less evident for mobility measures. Video-assisted composite measures may enhance the detection of treatment effects in MS clinical practice and trials.
评估运动功能对于监测多发性硬化症(MS)的病程很重要。对经典神经学测试和日常生活活动进行视频辅助评分可能会改善对运动功能变化的检测。我们研究了使用视频辅助综合测量来检测活动能力和上肢功能(UEF)变化的价值。
记录了43例MS患者在使用氨吡啶治疗前和治疗期间进行运动功能测试的情况。根据神经科医生对测试的评分,将患者在活动能力综合测量(MOB-COM)和UEF综合测量(UEF-COM)指标上分为改善或未改善。确定了综合测量与传统测量方法(25英尺定时步行测试(T25FW)和九孔插板测试(NHPT))之间的比例一致性,并与患者自我感知的改善情况进行比较,后者通过患者报告的活动能力和UEF变化评分来确定。
MOB-COM与T25FW之间的一致性为79.5%,UEF-COM与NHPT之间的一致性为82.1%。39例患者中有26例(66.7%)报告活动能力有所改善;其中6例报告同时得到T25FW和MOB-COM的证实,4例仅得到T25FW的证实,2例仅得到MOB-COM的证实。对于UEF,39例患者中有13例(33.3%)报告有所改善;其中3例得到NHPT的证实,3例得到UEF-COM的证实。
与传统的NHPT测量方法相比,视频辅助的UEF综合测量检测到了更多患者自我感知的改善情况。对于活动能力测量,这种情况不太明显。视频辅助综合测量可能会增强MS临床实践和试验中对治疗效果的检测。